Form 10-K Epizyme, Inc. For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Epizyme (EPZM) Tops Q4 EPS by 12c
March 9, 2016 6:33 AM ESTEpizyme (NASDAQ: EPZM) reported Q4 EPS of ($0.53), $0.12 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $555 thousand versus the consensus estimate of $570 thousand.
Based on these significant advancements throughout 2015, Epizyme has outlined a vision and strategic plan through 2020, focused on... More
